Legend Biotech (LEGN) is weighing a second listing outside of the US, Bloomberg reported, citing people familiar with the matter.
Possible locations include Hong Kong, Singapore and London, the report said.
Legend Biotech did not immediately respond to a request for comment from MT Newswires.
Shares of the company added more than 1% in recent trading Friday.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 35.60, Change: +0.61, Percent Change: +1.74